Treatment and Visualization of Pancreatic Ductal Adenocarcinoma through Actively Targeted Copper 64 Nanoparticles.
作者信息
MacCuaig William M, McNally Lacey R
出版信息
Radiol Imaging Cancer. 2021 Mar 26;3(2):e219005. doi: 10.1148/rycan.2021219005. eCollection 2021 Mar.
Abstract
摘要
相似文献
1
Treatment and Visualization of Pancreatic Ductal Adenocarcinoma through Actively Targeted Copper 64 Nanoparticles.通过主动靶向铜-64纳米颗粒对胰腺导管腺癌进行治疗与可视化
Radiol Imaging Cancer. 2021 Mar 26;3(2):e219005. doi: 10.1148/rycan.2021219005. eCollection 2021 Mar.
2
CC Chemokine Receptor 2-Targeting Copper Nanoparticles for Positron Emission Tomography-Guided Delivery of Gemcitabine for Pancreatic Ductal Adenocarcinoma.靶向CC趋化因子受体2的铜纳米颗粒用于正电子发射断层扫描引导下吉西他滨对胰腺导管腺癌的递送
ACS Nano. 2021 Jan 26;15(1):1186-1198. doi: 10.1021/acsnano.0c08185. Epub 2021 Jan 6.
3
EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model.用于吉西他滨在原位胰腺癌模型中全身给药的表皮生长因子受体靶向明胶纳米粒
Nanomedicine. 2016 Apr;12(3):589-600. doi: 10.1016/j.nano.2015.11.010. Epub 2015 Dec 3.
4
Self-Assembled Gemcitabine Prodrug Nanoparticles Show Enhanced Efficacy against Patient-Derived Pancreatic Ductal Adenocarcinoma.自组装吉西他滨前药纳米粒对患者来源的胰腺导管腺癌显示出增强的疗效。
ACS Appl Mater Interfaces. 2020 Jan 22;12(3):3327-3340. doi: 10.1021/acsami.9b16209. Epub 2020 Jan 7.
5
Icotinib plus gemcitabine for metastatic pancreatic cancer: a case report.埃克替尼联合吉西他滨治疗转移性胰腺癌：一例病例报告
World J Gastroenterol. 2015 Mar 21;21(11):3441-6. doi: 10.3748/wjg.v21.i11.3441.
6
A phase I, dose-finding study of sorafenib in combination with gemcitabine and radiation therapy in patients with unresectable pancreatic adenocarcinoma: a Grupo Español Multidisciplinario en Cáncer Digestivo (GEMCAD) study.一项索拉非尼联合吉西他滨及放疗用于不可切除胰腺腺癌患者的I期剂量探索性研究：西班牙多学科消化肿瘤研究组（GEMCAD）研究
PLoS One. 2014 Jan 9;9(1):e82209. doi: 10.1371/journal.pone.0082209. eCollection 2014.
7
How fast can pancreatic cancer grow? A case of pancreatic carcinoma developed within 5 months after a negative examination to the advanced stage with multiple liver and bone metastases.胰腺癌的生长速度有多快？有一例胰腺癌在一次检查结果为阴性后的5个月内就发展到了晚期，并伴有多处肝转移和骨转移。
Pancreas. 2011 Mar;40(2):318-9. doi: 10.1097/MPA.0b013e3181fe4031.
8
[Pancreatic carcinoma (ductal adenocarcinoma)].[胰腺癌（导管腺癌）]
Praxis (Bern 1994). 2005 Nov 16;94(46):1793-800; quiz 1801. doi: 10.1024/0369-8394.94.46.1793.
9
A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma.一项在晚期胰腺导管腺癌患者中联合吉西他滨应用激动型 CD40 单克隆抗体（CP-870,893）的 I 期研究。
Clin Cancer Res. 2013 Nov 15;19(22):6286-95. doi: 10.1158/1078-0432.CCR-13-1320. Epub 2013 Aug 27.
10
One year survival with poorly differentiated metastatic pancreatic carcinoma following chemoembolization with gemcitabine and cisplatin.吉西他滨和顺铂化疗栓塞治疗后分化不良转移性胰腺癌 1 年生存。
Oncol Rep. 2010 Sep;24(3):767-9. doi: 10.3892/or_00000919.
本文引用的文献
1
CC Chemokine Receptor 2-Targeting Copper Nanoparticles for Positron Emission Tomography-Guided Delivery of Gemcitabine for Pancreatic Ductal Adenocarcinoma.靶向CC趋化因子受体2的铜纳米颗粒用于正电子发射断层扫描引导下吉西他滨对胰腺导管腺癌的递送
ACS Nano. 2021 Jan 26;15(1):1186-1198. doi: 10.1021/acsnano.0c08185. Epub 2021 Jan 6.
Zotero 插件